Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Soleno Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:SLNO | Benzinga

Q: What sector and industry does Soleno Therapeutics (SLNO) operate in?

Soleno Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Soleno Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SLNO.

Open	-
Close	-
Volume / Avg.	832.00 / 1.22M
Day Range	- - -
52 Wk Range	36.93 - 76.56
Market Cap	$3.71B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	64
Short Interest	11.57%
Days to Cover	2.92

Recent News

Tesla To $455? Here Are 10 Top Analyst Forecasts For Monday

Avi Kapoor

Soleno Shares Are Up Today: What's Going On?

Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares are trading higher Thursday after the company announced it secured FDA approval for its first commercial drug, Vykat XR (diazoxide choline) extended-release tablets.

Vaishali Prayag

Gold Gains Over 1%; TD SYNNEX Shares Plunge After Downbeat Results

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	832.00 / 1.22M
Day Range	- - -
52 Wk Range	36.93 - 76.56
Market Cap	$3.71B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	64
Short Interest	11.57%
Days to Cover	2.92

About Soleno Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatme...

Got Questions? Ask

How is SLNO's EBITDA trending?

How is SLNO's revenue growing?

What are analysts' targets for SLNO?

What is the Pivot resistance level for SLNO?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Soleno Therapeutics (SLNO) stock?

You can purchase shares of Soleno Therapeutics (NASDAQ:SLNO) through any online brokerage.

View our list of the best stock brokerages

Who are Soleno Therapeutics (SLNO) competitors?

Other companies in Soleno Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and Ionis Pharmaceuticals (NASDAQ:IONS).

What is the forecast, or price target, for Soleno Therapeutics (SLNO) stock?

Soleno Therapeutics has a consensus price target of $101.22.

What is the current price for Soleno Therapeutics (SLNO)?

The stock price for Soleno Therapeutics (NASDAQ: SLNO) is $74.3 last updated May 5, 2025 at 7:14 AM EDT.

Does Soleno Therapeutics (SLNO) pay a dividend?

There are no upcoming dividends for Soleno Therapeutics.

When is Soleno Therapeutics (NASDAQ:SLNO) reporting earnings?

Soleno Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is Soleno Therapeutics (SLNO) going to split?

There is no upcoming split for Soleno Therapeutics.

What sector and industry does Soleno Therapeutics (SLNO) operate in?

Soleno Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Soleno Therapeutics Stock Price, Quotes and Forecasts

Soleno Therapeutics (SLNO) Forecast